Last10K.com

Bluebird Bio, Inc. (BLUE) SEC Filing 8-K Material Event for the period ending Thursday, July 26, 2018

Bluebird Bio, Inc.

HISTORY TOOLS
CIK: 1293971 Ticker: BLUE

View differences made from one to another to evaluate Bluebird Bio, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bluebird Bio, Inc..

Continue

Assess how Bluebird Bio, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bluebird Bio, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Bluebird Bio, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: BLUE
CIK: 1293971
Form Type: 8-K Corporate News
Accession Number: 0001564590-18-017623
Submitted to the SEC: Thu Jul 26 2018 4:45:04 PM EST
Accepted by the SEC: Thu Jul 26 2018
Period: Thursday, July 26, 2018
Industry: Biological Products No Disgnostic Substances
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/blue/0001564590-18-017623.htm